Suppression of natural killer activity by ascitic fluid from patients with gastrointestinal cancer.
D001202:Ascitic Fluid / Q000276:immunology*; D002460:Cell Line; D004306:Dose-Response Relationship, Immunologic; D005770:Gastrointestinal Neoplasms / Q000276:immunology*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D004915:Leukemia, Erythroblastic, Acute / Q000276:immunology